Halcyon Equity Partners S.C.A. SICAR (“Halcyon Equity Partners”), a Greek growth private equity fund focused on investing in mature Scale-up and Growth SMEs & Small Mid-Caps in Greece, is pleased to announce its strategic investment in AlfaOmega S.A. (“AlfaOmega”), the leading provider of pharmaceutical 3PL and 4PL services in Greece. This transaction reflects Halcyon’s continued commitment to investing in high-quality Greek companies with strong growth potential, as part of its broader “Invest in the Best of Greece” strategy.
Founded in 2008 and headquartered in Aspropyrgos, Attica, AlfaOmega has emerged as the key player in the provision of logistics and added-value services for pharmaceutical products across Greece. With an extended fleet of more than 200 temperature-controlled vehicles (owned and third party), a nationwide network reaching over 13,000 delivery points, and 27k m2 of specialized storage facilities, soon expanding to 54k m2, AlfaOmega plays a critical role in ensuring the safe and compliant storage and transport of pharmaceuticals. The Company’s robust infrastructure and deep sector expertise set it as the trusted logistics partner of choice for leading local and multinational pharmaceutical companies, hospitals and pharmacies.
AlfaOmega operates in a resilient and expanding industry, benefiting from Greece’s critical role in the supply chain over the last years, the overall increasing healthcare investments, the growing pharmaceutical exports and the ongoing sector consolidation. With Halcyon Equity Partners’ support, the Company is positioned to accelerate its next phase of growth through targeted investments in storage facilities, automation, the expansion of service offerings, and the integration of advanced quality management and sustainability practices. This partnership will unlock strategic, operational, and financial value while reinforcing AlfaOmega’s market position.
Evripidis Adamou, Founder and CEO of AlfaOmega, commented: “Over the past 15 years, AlfaOmega has established itself as the leading company in pharmaceutical logistics in Greece, built on a foundation of operational excellence, customer-centric service, and unwavering commitment to the safe and efficient supply chain services of pharmaceuticals. As we enter a new phase of growth, marked by the doubling of our storage capacity, automation of our operations, and expansion of our client base, we partner up with Halcyon Equity Partners that shares our vision, values and long-term ambition and provides value-added proposition, operational expertise and a clear roadmap for scaling businesses sustainably. Their commitment to innovation, ESG best practices, and strategic value creation made them the ideal partner for AlfaOmega’s next phase of growth.”
Lykourgos Galanopoulos, Partner at Halcyon Equity Partners, added: “AlfaOmega is a unique asset in a growing and resilient sector. We are proud to partner with Mr. Adamou and his exceptional team to accelerate the Company’s growth trajectory and further strengthen its market position, always keeping the customer in the spotlight of our attention.
This transaction was supported by Ernst & Young, First Floor Financial Engineering, Lambadarios Law Firm and PwC.
About Halcyon Equity Partners S.C.A. SICAR
Halcyon Equity Partners S.C.A. SICAR is a private equity fund that invests in mature Scale-up and Growth SMEs & Small Mid-Caps in Greece, with the goal of driving their growth. With assets under management of more than €170Μ, Halcyon Equity Partners focuses on companies with strong management teams across various sectors, depicting a competitive edge and a scalable business model, showing strong growth potential.